- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07699419
Impairment Based Treatment Versus Modified Functional Restoration Program in Chronic Low Back Pain Patients (FIRM-CLBP)
FIRM-CLBP: a Randomized Controlled Feasibility Trial Comparing Impairment-based Treatment With a Modified Functional Restoration Program in Older Adults With Chronic Low Back Pain
The aim of this feasibility study is to evaluate the practicality of conducting a future randomized controlled trial comparing two rehabilitation approaches for older adults with degenerative chronic low back pain: impairment-based treatment (IBT) and a modified short Functional Restoration Program (FRP).
Impairment-based treatment is an individualized approach in which interventions are tailored to the patient's specific physical deficits, such as limitations in mobility, strength, and motor control. In contrast, the Functional Restoration Program is a structured, standardized approach focusing on improving overall functional capacity through progressive exercise, movement retraining, and activity-based rehabilitation.
Participants will be randomly allocated to one of the two groups. Both interventions will be delivered by trained physiotherapists following standardized protocols over a 6-week period, with supervised sessions conducted according to a predefined rehabilitation schedule.
Обзор исследования
Статус
Вмешательство/лечение
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Mariam Wael, Bachelor of physiotherapy
- Номер телефона: 201117614968
- Электронная почта: merowael14@gmail.com
Места учебы
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Египет
- Recovery City Clinic
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Inclusion Criteria:
- ≥ 60 years
- Chronic Non-Specific Low Back Pain (CNSLBP)
- Pain duration ≥ 12 weeks
- No identifiable specific spinal pathology
- Pain Location
- Pain localized between the 12th rib and gluteal folds
- With or without non-dermatomal referred pain not extending below the knee
- Pain Intensity
- Mean pain intensity ≥ 4/10 on the Numeric Rating Scale (NRS) over the past 7 days
- Functional Disability
- Oswestry Disability Index (ODI) ≥ 20% (moderate disability or higher)
- Mechanical Pain Characteristics
- Presence of ≥ 2 of the following:
- Pain aggravated by movement, loading, or prolonged postures
- Pain relieved by rest or positional change
- Morning stiffness < 30 minutes
- Absence of constant, non-mechanical night pain Functional Capacity
- Able to ambulate independently (with or without assistive device)
- Able to actively participate in an exercise-based rehabilitation program
- Clinical Stability
- Stable medication regimen (analgesics, anti-inflammatories, or related drugs) for ≥ 4 weeks
- No planned changes in pharmacological treatment during the study period
- Cognitive & Communication Ability
- Able to understand study procedures and follow instructions
- MMSE ≥ 24 (or equivalent cognitive screening)
- Consent
- Provides written informed consent
Exclusion Criteria:
1. Specific Spinal Pathology ("Red Flags")
- Suspected or confirmed:
- Spinal fracture
- Malignancy
- Spinal infection
- Inflammatory spondyloarthropathy
Clinical indicators:
Unexplained weight loss Fever or systemic illness History of significant trauma
2. Radicular or Neurological Involvement
- Radiculopathy defined by ANY of:
- Dermatomal pain radiating below the knee
- Progressive motor weakness
Objective neurological deficit (sensory, reflex, or motor)
3. Lumbar Spinal Stenosis (Severe)
- Neurogenic claudication limiting walking to < 100 meters, OR
Symptoms not relieved by rest or flexion
4. Prior Surgical or Structural Conditions Lumbar spine surgery within the past 12 months
5. Medical Contraindications to Exercise
- Severe osteoporosis with high fracture risk
- Uncontrolled cardiovascular, respiratory, or metabolic disease
Any condition precluding safe participation in rehabilitation
6. Cognitive or Behavioral Barriers
- Severe cognitive impairment (MMSE < 24)
Inability to comply with study procedures
7. Confounding Treatment Factors
- Participation in structured physiotherapy or rehabilitation within the past 3 months
Planned concurrent rehabilitation during the study
8. Psychosocial Confounders Ongoing litigation or compensation claims related to low back pain
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Активный компаратор: Impairment-based treatment group
|
Subgroup 1 - Lumbar Mobility Deficits Clinical characteristics Localized low back pain Restricted lumbar range of motion Segmental hypomobility Pain at end-range movement Stiffness with prolonged posture Subgroup 2 - Movement Coordination Impairment Clinical characteristics Recurrent low back pain Pain aggravated by movement Poor trunk control Difficulty maintaining neutral spine Aberrant movement patterns during functional tasks Subgroup 3 - Low Back Pain with Referred Lower Extremity Pain (Non-Radicular) Clinical characteristics Low back pain associated with referred pain to the buttock or thigh (above the knee) No neurological deficit on examination Symptoms influenced by movement or loading Mechanical pain behavior
|
|
Активный компаратор: Modified short functional restoration program
|
The modified short Functional Restoration Program (FRP) is a structured, time-efficient rehabilitation approach designed to improve functional capacity in patients with chronic low back pain. It is based on a biopsychosocial model and combines progressive physical reconditioning with functional task training and patient education. The program includes aerobic conditioning, strengthening exercises, movement retraining, and graded activity exposure, with emphasis on restoring tolerance to daily activities rather than focusing solely on pain reduction. In this modified short version, the program is adapted for older adults and delivered over a limited timeframe, with standardized session content and progression criteria to ensure consistency, safety, and feasibility within a clinical outpatient setting. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Pain intensity
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
|
-Numerical pain rating scale (NPRS) from 1 to 10 , minimum 1 and maximum 10 .
The bigger the numbers means the worse .
|
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
|
|
Function
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
Modified Oswestry disability Index the MOLBPDQ consists of 10 patient-completed questions in which the response options are presented as 6-point Likert scales. Scores range from 0% (no disability) to 100% (most severe disability). |
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
|
Strength
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
|
Hand held dynamometer (activ force 2)
|
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
|
|
Eligibility rate
Временное ограничение: Post intervention (week 6)
|
Eligibility rate will be calculated as the proportion of screened participants who meet the study eligibility criteria. All individuals assessed for participation will be recorded, including those who are eligible and those who are excluded with reasons for exclusion. Eligibility Rate (%) = Number of Eligible Participants ÷ Number of Screened Participants × 100 |
Post intervention (week 6)
|
|
Retention
Временное ограничение: Post intervention (week 6) Follow up (1 month post intervention)
|
Participant Retention Rate Description: Percentage of enrolled participants who complete the study through the final follow-up assessment, as determined from study participation and completion records. Unit of Measure: Percentage (%) Measurement Tool: Study participation and completion records |
Post intervention (week 6) Follow up (1 month post intervention)
|
|
Intervention fidelity
Временное ограничение: Post intervention (week 6)
|
Percentage of predefined treatment components delivered according to the study protocol, as assessed using a standardized intervention fidelity checklist completed by an independent assessor during treatment sessions. Fidelity scores will be calculated as the proportion of protocol-required components successfully delivered. Unit of Measure: Percentage (%) Measurement Tool: Standardized Intervention Fidelity Checklist |
Post intervention (week 6)
|
|
Recruitment feasibility
Временное ограничение: Post intervention (weak 6)
|
Determine the recruitment rate (number of eligible and consenting participants per month) among older adults with degenerative chronic low back pain recruited from the clinical setting
|
Post intervention (weak 6)
|
|
Safety outcome
Временное ограничение: every session
|
The incidence, type, severity, and relatedness of any adverse events or undesirable effects potentially attributable to the rehabilitation intervention will be monitored and documented throughout the study period.
Adverse events may include increased pain, excessive fatigue, symptom aggravation, dizziness, discomfort during or after treatment, or any other unexpected clinical complaint reported by the participant or observed by the therapist.
|
every session
|
|
Data completeness
Временное ограничение: Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention
|
Data completeness will be assessed by calculating the proportion of completed outcome assessments at each assessment point out of the total expected outcome assessments.
Missing or incomplete data will be recorded and reported.
|
Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Adherence
Временное ограничение: Post intervention (week 6)
|
Participant adherence will be assessed throughout the intervention period using session attendance records, completion of the prescribed exercise program, and therapist documentation. Attendance adherence will be calculated as the percentage of attended treatment sessions out of the total scheduled sessions. Home exercise adherence will be monitored using a patient exercise diary or checklist, where participants record the frequency of performed exercises. Overall adherence will be considered acceptable when the participant completes at least 80% of the scheduled sessions and prescribed home exercises. Adherence rate will be calculated using the following formula: Adherence Rate (%) = Number of Completed Sessions or Exercises ÷ Total Prescribed Sessions or Exercises × 100 |
Post intervention (week 6)
|
|
Quality of Life outcome
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
|
Short Form 12 Item Health Survey Sf-12 , when the score gets higher it means better outcome.
|
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
|
|
Range of motion
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
Goniometer
|
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
|
Pressure pain threshold
Временное ограничение: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
Pressure pain threshold will be measured by pressure algometer using Kilogram as a unit of measurement.
|
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
|
|
Acceptability
Временное ограничение: Post-intervention: Week 6 Follow-up: 1 month post-intervention
|
Acceptability will be assessed using participant feedback regarding the practicality, ease of use, burden, and overall acceptability of the study procedures and measurement tools.
Feedback may be collected using a brief questionnaire, rating scale, or structured interview.
|
Post-intervention: Week 6 Follow-up: 1 month post-intervention
|
Соавторы и исследователи
Спонсор
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
- FIRM-CLBPstudy
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .